Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Obstetrics and Gynecology

Volume  7, Issue 3, July-September 2019, Pages 413-418
 

Review Article

Current Understanding and Practice in Menopause Hormone Therapy: Indian Perspective

Komal Gaur1, Sourabh B Fulmali2, Nalini Adele Pinto3

1Medical Advisor, 2Head Medical Affairs, 3Consultant Scienti c Communications lead, P zer India Ltd., New Delhi 110066, India

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/ijog.2321.1636.7319.11

Abstract

Background and Objectives: In spite of increasing awareness, controversies prevail among Obstetrics and Gynaecology healthcare practitioners (HCPs) regarding use of hormone therapy in the management of menopause. This study aimed to assess the current understanding and practices among HCPs in menopause hormonal therapy (MHT) in Tier I and II cities in North and West India. Methods: An MHT certification training course was conducted for HCPs by Pfizer Ltd. in partnership with Indian Menopause Society (IMS), and a subsequent clinic-based cross-sectional interviewer-administered survey was carried out. A section of questions was devoted to obtain feedback on the course. A total of 140 HCPs volunteered to complete the survey and data was reported using descriptive statistics. Results: Eighty nine out of 140 (64%) HCPs believed that hormone therapy should be routinely prescribed to symptomatic menopausal women. The two most common factors influencing initiation of MHT were severity of symptoms (76%) and age at presentation (53%). Conjugated estrogens were the first choice for 44% of HCPs in their prescribing practice and 43% preferred prescribing MHT for 6–12 months. All HCPs reported that the course helped them improve their understanding about menopause and most important learning point was that hormone therapy should be started early. Additionally, 96% of HCPs felt that refresher training in MHT would be beneficial for their practice. Conclusions: Menopause hormonal therapy is gaining acceptance as a preferred treatment in menopause management. However, reservations exist regarding the duration of therapy. Regular training may reinforce confidence of HCPs in prescribing MHT.


Keywords : Gynaecologists; Survey; Menopause management.
Corresponding Author : Komal Gaur